GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Redhill Biopharma RDHL · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.40

-7.69%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Redhill Biopharma

Our reporting

We have not reported on Redhill Biopharma yet.

Next results

18 Mar 2027

Due on 18 Mar 2027. Analysts expect earnings of -474.29 a share on revenue of $24.5m.

Past results

Reported against what analysts expected

5 Sept 202510 Apr 20253 Oct 202429 Jul 20248 Apr 202414 Mar 2024
Earnings per share-1.00-1.00-1.00-2.00-1.00-0.20
Forecast-690.00-690.00-690.00-0.30—-0.03
Revenue$2.0m$2.0m$2.7m$1.3m$1.3m$567,500
Forecast$4.4m$4.4m$4.4m$25.7m$25.7m$25.7m

Key events

  1. 7 Jan 2013Listed

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.